第一单位：
Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.;Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.;Tri-Institutional Computational Biology and Medicine PhD Program, Weill Cornell Medicine of Cornell University and Rockefeller University, New York, NY, USA.;The Rockefeller University, New York, NY, USA.
作者：
Yanis,Tazi [1]
;
Juan E,Arango-Ossa [2]
;
Yangyu,Zhou [2]
;
Elsa,Bernard [2]
;
Ian,Thomas [3]
;
Amanda,Gilkes [4]
;
Sylvie,Freeman [5]
;
Yoann,Pradat [6]
;
Sean J,Johnson [3]
;
Robert,Hills [7]
;
Richard,Dillon [8]
;
Max F,Levine [6]
;
Daniel,Leongamornlert [9]
;
Adam,Butler [9]
;
Arnold,Ganser [10]
;
Lars,Bullinger [11]
;
Konstanze,Döhner [12]
;
Oliver,Ottmann [4]
;
Richard,Adams [3]
;
Hartmut,Döhner [12]
;
Peter J,Campbell [9]
;
Alan K,Burnett [13]
;
Michael,Dennis [14]
;
Nigel H,Russell [15]
;
Sean M,Devlin [6]
;
Brian J P,Huntly [16]
;
Elli,Papaemmanuil [17]
作者单位：
Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.;Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.;Tri-Institutional Computational Biology and Medicine PhD Program, Weill Cornell Medicine of Cornell University and Rockefeller University, New York, NY, USA.;The Rockefeller University, New York, NY, USA.
[1]
Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.;Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
[2]
Centre for Trials Research, School of Medicine, Cardiff University, Cardiff, UK.
[3]
Department of Haematology, School of Medicine, Cardiff University, Cardiff, UK.
[4]
Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
[5]
Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
[6]
Nuffield Department of Population Health, University of Oxford, Oxford, UK.
[7]
Department of Medical and Molecular Genetics, King's College, London, UK.
[8]
Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK.
[9]
Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
[10]
Department of Hematology, Oncology, and Tumorimmunology, Campus Virchow Klinikum, Berlin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
[11]
Department of Internal Medicine III, Ulm University, Ulm, Germany.
[12]
Visiting Professor University of Glasgow, formerly Cardiff University, Cardiff, UK.
[13]
The Christie NHS Foundation Trust, Manchester, UK.
[14]
Department of Haematology, Nottingham University Hospital, Nottingham, UK.
[15]
Department of Haematology and Wellcome Trust-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
[16]
Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. papaemme@mskcc.org.;Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA. papaemme@mskcc.org.
[17]
DOI
10.1038/s41467-022-32103-8
PMID
35941135
发布时间
2025-05-30
换一批
